跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TACROLIMUS STADAFARMA 3 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TACROLIMUS STADAFARMA 3 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG
Approved
STANDARD
TACROLIMUS STADAFARMA 3 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG
Laboratorio Stada S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 12, 2022
Approval ID
2df940085b347d25
Company
Laboratorio Stada S.L.
Type
Standard
Approval Details
Approval Id
2df940085b347d25
Drug Cima Aemps Name
TACROLIMUS STADAFARMA 3 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG
Register Number
88080
Holder Company Name
Laboratorio Stada S.L.
Marketing Company Name
Laboratorio Stada S.L.
Authorization Date
2022-09-12
Dosage Form
CÁPSULA DURA DE LIBERACIÓN PROLONGADA
Dose
3 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Laboratorio Stada S.L.
Active Ingredients
TACROLIMUS MONOHIDRATO
3,0659 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 12, 2022
Approval ID
2df940085b347d25
Type
Standard
Back to CIMA-AEMPS Approvals